APC Panel Calls For External Data To Resolve Outpatient Payment Issues
This article was originally published in The Gray Sheet
Executive Summary
CMS' Ambulatory Payment Classification Advisory Panel recommended the agency incorporate external data to settle discrepancies with device-related payment groupings in the outpatient prospective payment system
You may also be interested in...
Stakeholders To Address CMS Advisory Panel On Outpatient Payment Issues
Prosthetic urologists will be among device stakeholders seeking improved Medicare outpatient payment in 2005 when CMS' Ambulatory Payment Classification Advisory Panel convenes in Baltimore Sept. 1-3
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.